At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMRN Amarin Corp PLC
Pre-Mkt 01-12 07:29:08 EST
15.82
-0.58
-3.54%
High16.80Low15.67Vol114.40K
Open16.51D1 Closing16.40Amplitude6.89%
Mkt Cap328.94MTradable Cap296.72MTotal Shares20.79M
T/O1.85MT/O Rate0.61%Tradable Shares18.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Amarin comments on recent innovations for patients with elevated triglycerides
TIPRANKS  ·  01-09
Amarin comments on recent innovations for patients with elevated triglycerides
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
GlobeNewswire  ·  01-09
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
Amarin Shares Rise on Hitting Positive Cash Flow Ahead of Expectations
Dow Jones  ·  01-09
Amarin Shares Rise on Hitting Positive Cash Flow Ahead of Expectations
Amarin Reports $217M Revenue and $303M Cash in Preliminary Full-Year 2025 Results
Benzinga  ·  01-08
Amarin Reports $217M Revenue and $303M Cash in Preliminary Full-Year 2025 Results
Amarin Corp - Realizes 50% of $70 Mln Opex Savings Related to 2025 Restructuring
THOMSON REUTERS  ·  01-08
Amarin Corp - Realizes 50% of $70 Mln Opex Savings Related to 2025 Restructuring
Amarin Corp: Expected Restructuring Costs to Range From $37 - $40 Mln in 2025
THOMSON REUTERS  ·  01-08
Amarin Corp: Expected Restructuring Costs to Range From $37 - $40 Mln in 2025
Amarin Corp - Expects Q4 2025 Revenue Between $48-$53 Mln
THOMSON REUTERS  ·  01-08
Amarin Corp - Expects Q4 2025 Revenue Between $48-$53 Mln
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
GlobeNewswire  ·  01-08
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
MT Newswires Live  ·  01-08
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Rise Tuesday
MT Newswires Live  ·  2025-12-31
European Equities Traded in the US as American Depositary Receipts Rise Tuesday
European Equities Traded in the US as American Depositary Receipts Little Changed in Friday Trading; Gains 2% for Week
MT Newswires Live  ·  2025-12-27
European Equities Traded in the US as American Depositary Receipts Little Changed in Friday Trading; Gains 2% for Week
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading
MT Newswires Live  ·  2025-12-19
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
MT Newswires Live  ·  2025-12-16
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
MT Newswires Live  ·  2025-12-11
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European Equities Traded in the US as ADRs Little Changed in Monday Trading
MT Newswires Live  ·  2025-12-09
European Equities Traded in the US as ADRs Little Changed in Monday Trading
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading
MT Newswires Live  ·  2025-11-14
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading
MT Newswires Live  ·  2025-11-11
European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading
Amarin announces new post hoc analysis of aspirin use in REDUCE-IT
TIPRANKS  ·  2025-11-10
Amarin announces new post hoc analysis of aspirin use in REDUCE-IT
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
GlobeNewswire  ·  2025-11-10
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
MT Newswires Live  ·  2025-11-07
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

Introduction

Company Name.
Amarin Corp PLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Issue price:
--